Mayne Pharma | 销售

股票价格
2.63
每天变化
-0.07 -2.59%
每月一次
-17.81%
每年
-43.80%
Q1 预测
2.58


金融业
股票价格
AUD
资产
AUD 1.14B
现金及等价物
AUD 110.07M
销售成本
AUD 43.74M
流动资产
AUD 460.59M
流动负债
AUD 313.94M
债务
AUD 38.82M
EBIT
AUD -16.2M
EBITDA
AUD 20.9M
员工
450
EPS每股收益
AUD -0.89
股本和储备
AUD 454.19M
销售毛利
AUD 86.13M
债务利息支出
AUD 1.2M
贷款资金
AUD 2.66M
市值
AUD 223.75M
净收入
AUD -103.68M
营业费用
AUD 103.54M
营业利润
AUD -3.3M
普通股股本
AUD 81.25M
税前利润
AUD -14.7M
销售收入
AUD 195.04M
销售和管理费用
AUD 54.8M
股票
AUD 74.63M
贸易债权人
AUD 30.25M
应收帐款人
AUD 193.22M


销售 更改 日
Ansell USD 834.4M 49.5M 2024-06
Avita Medical AUD 18.42M 14K 2025-06
Cochlear AUD 585.65M 586.15M 2025-06
CSL USD 3.54B 4.68B 2025-06
Healius AUD 933.9M 485.3M 2024-12
Integral Diagnostics AUD 238.44M 7.19M 2024-06
Medical Developments International AUD 9.53M 1.99M 2025-06
Nanosonics AUD 105.03M 11.44M 2025-06
Polynovo AUD 34.58M 24.94M 2025-06
Ramsay Health Care AUD 9.29B 32.2M 2025-12
ResMed USD 1.42B 87.23M 2025-12
Sigma Healthcare AUD 1.68B 188.65M 2024-12
Sonic Healthcare AUD 4.98B 311M 2025-06
Telix Pharmaceuticals AUD 309.72M 109.32M 2025-06


Mayne Pharma 销售 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.